Plain-English translation of NCT03711110 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The CARTIER trial is testing whether intensive heart monitoring—combined with specialized care from doctors who understand both cancer and heart health—can help older adults with cancer live longer and healthier lives. Some patients will receive this new, close heart-monitoring approach, while others will receive standard cancer care. The study will follow patients for up to 5 years to see which approach works better.
Some cancer medications can damage the heart, but these side effects are often caught too late. This trial is trying to solve that problem by catching heart damage early through close monitoring, so doctors can treat it before it becomes serious.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: either the intensive heart-monitoring group or the standard care group. If you are in the monitoring group, you will have regular heart check-ups and scans (like echocardiograms and blood tests) performed by a team that specializes in heart health for cancer patients. All participants will be followed for 2 to 5 years, with visits and assessments to track your overall health, heart function, and cancer progress.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Spain